Steven Cohen Point72 Asset Management
Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$372M |
| 2 |
Amazon
AMZN
|
+$228M |
| 3 |
Analog Devices
ADI
|
+$121M |
| 4 |
United Therapeutics
UTHR
|
+$105M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$97.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$238M |
| 2 |
DXC Technology
DXC
|
+$235M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$183M |
| 4 |
NXP Semiconductors
NXPI
|
+$158M |
| 5 |
Baidu
BIDU
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.57% |
| 2 | Healthcare | 20.55% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 7.32% |
| 5 | Communication Services | 6.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
CACI
CACI
$14.3B
| $23.2M | 0.1% |
90,839
-68,876
| -43% | -$17.8M |
|
252
Takeda Pharmaceutical
TAK
$58.1B
| $23.2M | 0.1% |
+1,377,000
| New | +$23.4M |
|
253
Coca-Cola Europacific Partners
CCEP
$47.7B
| $23.2M | 0.1% |
390,436
+51,067
| +15% | +$2.98M |
|
|
NSTG
254
DELISTED
NanoString Technologies, Inc.
NSTG
| $23.1M | 0.1% |
356,937
+90,463
| +34% | +$5.74M |
|
|
BPMC
255
DELISTED
Blueprint Medicines
BPMC
| $22.9M | 0.1% |
+260,844
| New | +$23.9M |
|
256
Bread Financial
BFH
$4.07B
| $22.7M | 0.1% |
273,030
-12,530
| -4% | -$1.13M |
|
257
Walt Disney
DIS
$186B
| $22.6M | 0.1% |
+128,842
| New | +$23.2M |
|
258
HF Sinclair
DINO
$17.3B
| $22.6M | 0.1% |
+686,690
| New | +$23.9M |
|
259
Canadian National Railway
CNI
$78.5B
| $22.5M | 0.1% |
213,300
-400,568
| -65% | -$44.2M |
|
260
Forte Biosciences
FBRX
$1.63B
| $22.5M | 0.1% |
26,738
+6,730
| +34% | +$6.06M |
|
|
SCHW
261
Charles Schwab
SCHW
$194B
| $22.4M | 0.1% |
+308,200
| New | +$21.8M |
|
262
Avantor
AVTR
$9.78B
| $22.4M | 0.1% |
630,786
+48,286
| +8% | +$1.56M |
|
263
Markel Group
MKL
$22.2B
| $22.3M | 0.1% |
18,752
-4,010
| -18% | -$4.81M |
|
264
Plug Power
PLUG
$3.17B
| $22.1M | 0.1% |
+645,312
| New | +$18.7M |
|
265
Lyft
LYFT
$6.61B
| $22M | 0.1% |
363,685
-429,569
| -54% | -$24.7M |
|
266
AptarGroup
ATR
$8.57B
| $21.8M | 0.1% |
+155,100
| New | +$22.9M |
|
|
EA
267
DELISTED
Electronic Arts
EA
| $21.6M | 0.1% |
+150,286
| New | +$21.3M |
|
268
Spotify
SPOT
$110B
| $21.4M | 0.1% |
+77,620
| New | +$19.7M |
|
269
Morgan Stanley
MS
$336B
| $21.3M | 0.1% |
232,700
-200,700
| -46% | -$17.2M |
|
270
iRhythm Holdings
IRTC
$4.24B
| $21.3M | 0.1% |
+321,211
| New | +$25.5M |
|
271
Air Products & Chemicals
APD
$67.9B
| $21.3M | 0.1% |
74,052
-22,773
| -24% | -$6.68M |
|
272
Hershey
HSY
$37.5B
| $21.3M | 0.1% |
122,293
-94,920
| -44% | -$16M |
|
273
Elanco Animal Health
ELAN
$12B
| $21.3M | 0.1% |
612,900
-1,777,000
| -74% | -$58.6M |
|
274
Sutro Biopharma
STRO
$349M
| $21.1M | 0.09% |
113,660
+17,840
| +19% | +$3.49M |
|
|
ALLK
275
DELISTED
Allakos
ALLK
| $21.1M | 0.09% |
247,300
+127,400
| +106% | +$12.7M |
|
Similar funds
Steven Cohen's Q2 2021 Portfolio in Review
As of Q2 2021, Steven Cohen held 1,274 positions worth $22.3B, up 4% from $21.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Steven Cohen's Q2 2021 filing shows 347 new, 260 increased, 248 reduced and 334 closed positions. Its largest new stake was United Therapeutics: 552,400 shares worth $99.1M. The largest sale was Applied Materials, an estimated $238M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Steven Cohen's largest Q2 2021 buy was United Therapeutics: 552,400 shares worth $99.1M.
- Steven Cohen added most to Salesforce in Q2 2021, an estimated $372M increase.
- Steven Cohen's biggest Q2 2021 reduction was Applied Materials, cutting an estimated $238M.
- Steven Cohen fully exited DXC Technology in Q2 2021, selling an estimated $235M.
- Steven Cohen's ten largest holdings make up 18% of its $22.3B portfolio in Q2 2021.
- Steven Cohen opened 347 new positions and closed 334 in Q2 2021.
- Steven Cohen's portfolio value rose 4% quarter-over-quarter to $22.3B.
Based on Point72 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.